Optimization of [11C]methionine PET study: appropriate scan timing and effect of plasma amino acid concentrations on the SUV.

Abstract:

BACKGROUND:[11C]methionine (MET) has been used to monitor amino acid metabolism in tumors, the pancreas, liver, and myocardium. The aim of the present study was to standardize [11C]MET positron emission tomography (PET) by optimizing the timing of initiation of the scan and applying correction to the plasma concentrations of neutral amino acids (NAAs), where necessary. METHODS:Sequential whole-body MET PET/computed tomography (CT) was performed in 11 normal adults after they had fasted for at least 4 h. After whole-body CT for attenuation correction and intravenous bolus injection of MET, the subjects were scanned from the parietal to the groin. The scanning was repeated six to seven times. Decay of radioactivity during the PET scan was corrected to the time of initiation of the first scan. The standardized uptake values (SUVs) were evaluated in various organs by setting regions of interest on the tomographic images. Plasma concentrations of NAAs were examined in relation to the SUV values. RESULTS:The SUVs in the pancreas reached their plateau from 6.5 to 11 min after the MET injection, and in the brain, lung, and myocardium, they reached their plateau from 19.6 to 24.1 min. The MET uptake in the spleen and kidney peaked early after the injection and steadily decreased thereafter. The SUVs in the liver and stomach wall rapidly increased during the first 0 to 4.5 min and gradually elevated thereafter during the scan period. Urinary radioactivity in the bladder reached its plateau from 26.1 to 30.6 min after the MET injection. There were no correlations between the plasma concentrations of NAAs and the maximal SUV in any organs. CONCLUSIONS:The present study revealed the times taken to reach the plateau of MET uptake in various important organs, and little effects of the plasma neutral amino acid concentrations on the SUVs in PET studies conducted after the patients had fasted for at least 4 h. In the MET PET study, 4 h fasting period before MET administration and the scan initiation 20 min after MET administration provide the SUV values independent of scan initiation time and the plasma neutral amino acid concentrations.

journal_name

EJNMMI Res

journal_title

EJNMMI research

authors

Isohashi K,Shimosegawa E,Kato H,Kanai Y,Naka S,Fujino K,Watabe H,Hatazawa J

doi

10.1186/2191-219X-3-27

subject

Has Abstract

pub_date

2013-04-15 00:00:00

pages

27

issue

1

issn

2191-219X

pii

2191-219X-3-27

journal_volume

3

pub_type

杂志文章
  • Effects of common anesthetic agents on [18F]flumazenil binding to the GABAA receptor.

    abstract:BACKGROUND:The availability of GABAA receptor binding sites in the brain can be assessed by positron emission tomography (PET) using the radioligand, [18F]flumazenil. However, the brain uptake and binding of this PET radioligand are influenced by anesthetic drugs, which are typically needed in preclinical imaging studi...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-016-0235-2

    authors: Palner M,Beinat C,Banister S,Zanderigo F,Park JH,Shen B,Hjoernevik T,Jung JH,Lee BC,Kim SE,Fung L,Chin FT

    更新日期:2016-12-01 00:00:00

  • The effect of isoflurane on 18F-FDG uptake in the rat brain: a fully conscious dynamic PET study using motion compensation.

    abstract:BACKGROUND:In preclinical positron emission tomography (PET) studies an anaesthetic is used to ensure that the animal does not move during the scan. However, anaesthesia may have confounding effects on the drug or tracer kinetics under study, and the nature of these effects is usually not known. METHOD:We have impleme...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-016-0242-3

    authors: Spangler-Bickell MG,de Laat B,Fulton R,Bormans G,Nuyts J

    更新日期:2016-12-01 00:00:00

  • Blocking of efflux transporters in rats improves translational validation of brain radioligands.

    abstract:BACKGROUND:Positron emission tomography (PET) is a molecular imaging technique that can be used to investigate the in vivo pharmacology of drugs. Initial preclinical evaluation of PET tracers is often conducted in rodents due to the accessibility of disease models as well as economic considerations. Compared to larger ...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-020-00718-x

    authors: Shalgunov V,Xiong M,L'Estrade ET,Raval NR,Andersen IV,Edgar FG,Speth NR,Baerentzen SL,Hansen HD,Donovan LL,Nasser A,Peitersen ST,Kjaer A,Knudsen GM,Syvänen S,Palner M,Herth MM

    更新日期:2020-10-19 00:00:00

  • Gut microbiota and physiologic bowel 18F-FDG uptake.

    abstract:BACKGROUND:We investigated the association between physiologic bowel FDG uptake and gut microbiota. FDG uptake in the normal large and small intestine is widely variable both in distribution and intensity. The etiology of physiologic bowel 18F-FDG activity remains unknown. RESULTS:We included 63 healthy male subjects....

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-017-0318-8

    authors: Kang JY,Kim HN,Chang Y,Yun Y,Ryu S,Shin H,Kim HL

    更新日期:2017-08-31 00:00:00

  • Measuring dopaminergic function in the 6-OHDA-lesioned rat: a comparison of PET and microdialysis.

    abstract:BACKGROUND:[18 F]fluorodopa (FDOPA) positron emission tomography (PET) allows assessment of levodopa (LDOPA) metabolism and is widely used to study Parkinson's disease. We examined how [18 F]FDOPA PET-derived kinetic parameters relate the dopamine (DA) and DA metabolite content of extracellular fluid measured by microd...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/2191-219X-3-69

    authors: Walker MD,Dinelle K,Kornelsen R,Lee A,Farrer MJ,Stoessl AJ,Sossi V

    更新日期:2013-10-02 00:00:00

  • Bone Scan Index as a prognostic imaging biomarker during androgen deprivation therapy.

    abstract:BACKGROUND:Bone Scan Index (BSI) is a quantitative measurement of tumour burden in the skeleton calculated from bone scan images. When analysed at the time of diagnosis, it has been shown to provide prognostic information on survival in men with metastatic prostate cancer (PCa). In this study, we evaluated the prognost...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-014-0058-y

    authors: Reza M,Bjartell A,Ohlsson M,Kaboteh R,Wollmer P,Edenbrandt L,Trägårdh E

    更新日期:2014-10-17 00:00:00

  • Quantitative performance and optimal regularization parameter in block sequential regularized expectation maximization reconstructions in clinical 68Ga-PSMA PET/MR.

    abstract:BACKGROUND:In contrast to ordered subset expectation maximization (OSEM), block sequential regularized expectation maximization (BSREM) positron emission tomography (PET) reconstruction algorithms can run until full convergence while controlling image quality and noise. Recent studies with BSREM and 18F-FDG PET reporte...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-018-0414-4

    authors: Ter Voert EEGW,Muehlematter UJ,Delso G,Pizzuto DA,Müller J,Nagel HW,Burger IA

    更新日期:2018-07-27 00:00:00

  • Cyclosporin A, but not tacrolimus, negatively affects the hepatic extraction fraction of hepatobiliary scintigraphy in liver transplant recipients.

    abstract:BACKGROUND:Hepatobiliary scintigraphy using (99m)Tc-mebrofenin has been used as an investigation to study liver function after liver transplantation (LTx). Hepatic extraction fraction (HEF) is a measurement of the hepatic extraction efficiency and hepatic extraction rate. With the purpose of evaluating a possible diver...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-014-0073-z

    authors: Kaxiras A,Yamamoto S,Söderdahl G,Wernerson A,Axelsson R,Ericzon BG

    更新日期:2014-12-01 00:00:00

  • A new 68Ga-labeled somatostatin analog containing two iodo-amino acids for dual somatostatin receptor subtype 2 and 5 targeting.

    abstract:BACKGROUND:Somatostatin receptor (SST) targeting, specifically of the subtype 2 (SST2), with radiolabeled somatostatin analogs, is established for imaging and treatment of neuroendocrine tumors. Owing to the concomitant and heterogeneous expression of several subtypes on the same tumor, analogs targeting more subtypes ...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-020-00677-3

    authors: Mansi R,Abid K,Nicolas GP,Del Pozzo L,Grouzmann E,Fani M

    更新日期:2020-08-05 00:00:00

  • Detection of murine post-pneumonectomy lung regeneration by 18FDG PET imaging.

    abstract:UNLABELLED: BACKGROUND:An intriguing biologic process in most adult mammals is post-pneumonectomy lung regeneration, that is, the removal of one lung (pneumonectomy) results in the rapid compensatory growth of the remaining lung. The spatial dependence and metabolic activity of the rodent lung during compensatory lung...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/2191-219X-2-48

    authors: Gibney BC,Park MA,Chamoto K,Ysasi A,Konerding MA,Tsuda A,Mentzer SJ

    更新日期:2012-09-21 00:00:00

  • The significance of equivocal bone findings in staging PSMA imaging in the preoperative setting: validation of the PSMA-RADS version 1.0.

    abstract:BACKGROUND:Assessing the extent of disease in newly diagnosed prostate cancer (PC) patients is crucial for tailoring an appropriate treatment approach. Prostate-specific membrane antigen (PSMA)-targeted positron emission tomography/computed tomography (PET/CT) reportedly has greater accuracy than conventional imaging f...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-020-00745-8

    authors: Kuten J,Dekalo S,Mintz I,Yossepowitch O,Mano R,Even-Sapir E

    更新日期:2021-01-06 00:00:00

  • Effect of postconditioning on dynamic expression of tenascin-C and left ventricular remodeling after myocardial ischemia and reperfusion.

    abstract:BACKGROUND:Tenascin-C (TNC), an extracellular matrix glycoprotein, is expressed transiently in distinct areas in association with active tissue remodeling. This study aimed to explore how ischemic postconditioning (PC) affects myocardial expression of TNC and ventricular remodeling using (125)I-labeled anti-TNC antibod...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-015-0100-8

    authors: Taki J,Inaki A,Wakabayashi H,Matsunari I,Imanaka-Yoshida K,Ogawa K,Hiroe M,Shiba K,Yoshida T,Kinuya S

    更新日期:2015-04-02 00:00:00

  • Identifying erlotinib-sensitive non-small cell lung carcinoma tumors in mice using [(11)C]erlotinib PET.

    abstract:BACKGROUND:Non-small cell lung carcinoma (NSCLC) represents approximately 80% of lung cancer cases, and over 60% of these tumors express the epidermal growth factor receptor (EGFR). Activating mutations in the tyrosine kinase (TK) domain of the EGFR are detected in 10% to 30% of NSCLC patients, and evidence of their pr...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-014-0080-0

    authors: Abourbeh G,Itamar B,Salnikov O,Beltsov S,Mishani E

    更新日期:2015-02-12 00:00:00

  • Quantitative 18F-FDG PET-CT scan characteristics correlate with tuberculosis treatment response.

    abstract:BACKGROUND:There is a growing interest in the use of F-18 FDG PET-CT to monitor tuberculosis (TB) treatment response. Tuberculosis lung lesions are often complex and diffuse, with dynamic changes during treatment and persisting metabolic activity after apparent clinical cure. This poses a challenge in quantifying scan-...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-020-0591-9

    authors: Malherbe ST,Chen RY,Dupont P,Kant I,Kriel M,Loxton AG,Smith B,Beltran CGG,van Zyl S,McAnda S,Abrahams C,Maasdorp E,Doruyter A,Via LE,Barry CE 3rd,Alland D,Richards SG,Ellman A,Peppard T,Belisle J,Tromp G,Ronache

    更新日期:2020-02-10 00:00:00

  • Targeted beta therapy of prostate cancer with 177Lu-labelled Miltuximab® antibody against glypican-1 (GPC-1).

    abstract:PURPOSE:Chimeric antibody Miltuximab®, a human IgG1 engineered from the parent antibody MIL-38, is in clinical development for solid tumour therapy. Miltuximab® targets glypican-1 (GPC-1), a cell surface protein involved in tumour growth, which is overexpressed in solid tumours, including prostate cancer (PCa). This st...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-020-00637-x

    authors: Yeh MC,Tse BWC,Fletcher NL,Houston ZH,Lund M,Volpert M,Stewart C,Sokolowski KA,Jeet V,Thurecht KJ,Campbell DH,Walsh BJ,Nelson CC,Russell PJ

    更新日期:2020-05-07 00:00:00

  • Quantification of pulmonary disease activity in sarcoidosis measured with 18F-FDG PET/CT: SUVmax versus total lung glycolysis.

    abstract:BACKGROUND:18F-FDG PET/CT has proven to be a reliable tool for therapy monitoring in sarcoidosis. Previous PET studies investigated the SUVmax as a marker for disease activity. Total lung glycolysis (TLuG) is a new tool, quantifying the glycolysis of the entire lung. Since SUVmax represents the maximum activity in only...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-019-0505-x

    authors: Schimmelpennink MC,Vorselaars ADM,Veltkamp M,Keijsers RGM

    更新日期:2019-06-13 00:00:00

  • Imaging cerebral tryptophan metabolism in brain tumor-associated depression.

    abstract:BACKGROUND:Depression in patients with brain tumors is associated with impaired quality of life and shorter survival. Altered metabolism of tryptophan to serotonin and kynurenine metabolites may play a role in tumor-associated depression. Our recent studies with alpha[(11)C]methyl-L-tryptophan (AMT)-PET in brain tumor ...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-015-0136-9

    authors: Bosnyák E,Kamson DO,Behen ME,Barger GR,Mittal S,Juhász C

    更新日期:2015-12-01 00:00:00

  • Low septal to lateral wall 18F-FDG ratio is highly associated with mechanical dyssynchrony in non-ischemic CRT candidates.

    abstract:BACKGROUND:In order to better understand the concept of mechanical dyssynchrony, a promising hallmark of cardiac resynchronization therapy (CRT) response, we investigated its effect on regional myocardial metabolism and myocardial blood flow (MBF) in non-ischemic CRT candidates. RESULTS:Thirty consecutive non-ischemic...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-019-0575-9

    authors: Degtiarova G,Claus P,Duchenne J,Cvijic M,Schramm G,Nuyts J,Voigt JU,Gheysens O

    更新日期:2019-12-09 00:00:00

  • Long fasting is effective in inhibiting physiological myocardial 18F-FDG uptake and for evaluating active lesions of cardiac sarcoidosis.

    abstract:BACKGROUND:F-fluorodeoxyglucose (FDG) positron emission tomography (PET) is a promising modality for detecting active lesions of cardiac sarcoidosis (CS). However, determining whether 18F-FDG uptake in the myocardium is physiological is challenging due to metabolic shift in myocardial cells. Although methods for inhibi...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/2191-219X-4-1

    authors: Morooka M,Moroi M,Uno K,Ito K,Wu J,Nakagawa T,Kubota K,Minamimoto R,Miyata Y,Okasaki M,Okazaki O,Yamada Y,Yamaguchi T,Hiroe M

    更新日期:2014-01-02 00:00:00

  • Multimodality imaging using SPECT/CT and MRI and ligand functionalized 99mTc-labeled magnetic microbubbles.

    abstract:BACKGROUND:In the present study, we used multimodal imaging to investigate biodistribution in rats after intravenous administration of a new 99mTc-labeled delivery system consisting of polymer-shelled microbubbles (MBs) functionalized with diethylenetriaminepentaacetic acid (DTPA), thiolated poly(methacrylic acid) (PMA...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/2191-219X-3-12

    authors: Barrefelt AA,Brismar TB,Egri G,Aspelin P,Olsson A,Oddo L,Margheritelli S,Caidahl K,Paradossi G,Dähne L,Axelsson R,Hassan M

    更新日期:2013-02-25 00:00:00

  • A pretargeted multimodal approach for image-guided resection in a xenograft model of colorectal cancer.

    abstract:BACKGROUND:Image-guided surgery may improve surgical outcome for colorectal cancer patients. Here, we evaluated the feasibility of a pretargeting strategy for multimodal imaging in colorectal cancer using an anti-carcinoembryonic antigen (CEA) x anti-histamine-succinyl-glycine (HSG) bispecific antibody (TF2) in conjunc...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-019-0551-4

    authors: Elekonawo FMK,Lütje S,Franssen GM,Bos DL,Goldenberg DM,Boerman OC,Rijpkema M

    更新日期:2019-09-04 00:00:00

  • VEGF receptor targeted imaging of angiogenic response to limb ischemia in diabetic vs. non-diabetic Yucatan minipigs.

    abstract:BACKGROUND:New therapies to treat diabetic peripheral artery disease (PAD) require target-specific non-invasive imaging modalities to follow efficacy. As a translational study, we performed targeted imaging of receptors for vascular endothelial growth factor (VEGF) in response to anterior femoral artery occlusion (FAO)...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-020-00626-0

    authors: Johnson LL,Johnson J,Ali Z,Tekabe Y,Ober R,Geist G,McLuckie A,Safarov A,Holland A,Zhang G,Backer M,Backer J

    更新日期:2020-05-12 00:00:00

  • Interobserver agreement of [68Ga]Ga-PSMA-11 PET/CT images interpretation in men with newly diagnosed prostate cancer.

    abstract:BACKGROUND:Prostate-specific membrane antigen (PSMA) ligand PET/CT has already provided promising results in prostate cancer (PC) imaging, yet simple and reproductible reporting criteria are still lacking. This study aimed at retrospectively evaluating interobserver agreement of [68Ga]Ga-PSMA-11 PET/CT images interpret...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-020-0596-4

    authors: Derwael C,Lavergne O,Lovinfosse P,Nechifor V,Salvé M,Waltregny D,Hustinx R,Withofs N

    更新日期:2020-02-28 00:00:00

  • Hepatobiliary scintigraphy may improve radioembolization treatment planning in HCC patients.

    abstract:BACKGROUND:Routine work-up for transarterial radioembolization, based on clinical and laboratory parameters, sometimes fails, resulting in severe hepatotoxicity in up to 5% of patients. Quantitative assessment of the pretreatment liver function and its segmental distribution, using hepatobiliary scintigraphy may improv...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-016-0248-x

    authors: Braat MNGJA,de Jong HW,Seinstra BA,Scholten MV,van den Bosch MAAJ,Lam MGEH

    更新日期:2017-12-01 00:00:00

  • Binding of TS1, an anti-keratin 8 antibody, in small-cell lung cancer after 177Lu-DOTA-Tyr3-octreotate treatment: a histological study in xenografted mice.

    abstract:BACKGROUND:Small-cell lung carcinoma (SCLC) is an aggressive malignancy characterised by an early relapse, a tendency towards drug resistance, and a high incidence of metastasis. SCLC cells are of neuroendocrine origin and express high levels of somatostatin receptors; therefore, future treatment might involve targetin...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/2191-219X-1-19

    authors: Erlandsson A,Forssell-Aronsson E,Seidal T,Bernhardt P

    更新日期:2011-08-26 00:00:00

  • Metabolic liver function in humans measured by 2-18F-fluoro-2-deoxy-D-galactose PET/CT-reproducibility and clinical potential.

    abstract:BACKGROUND:PET/CT with the radioactively labelled galactose analogue 2-18F-fluoro-2-deoxy-D-galactose (18F-FDGal) can be used to quantify the hepatic metabolic function and visualise regional metabolic heterogeneity. We determined the day-to-day variation in humans with and without liver disease. Furthermore, we examin...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-017-0320-1

    authors: Bak-Fredslund KP,Lykke Eriksen P,Munk OL,Villadsen GE,Keiding S,Sørensen M

    更新日期:2017-08-29 00:00:00

  • Improved safety and efficacy of 213Bi-DOTATATE-targeted alpha therapy of somatostatin receptor-expressing neuroendocrine tumors in mice pre-treated with L-lysine.

    abstract:BACKGROUND:Targeted alpha therapy (TAT) offers advantages over current β-emitting conjugates for peptide receptor radionuclide therapy (PRRT) of neuroendocrine tumors. PRRT with 177Lu-DOTATATE or 90Y-DOTATOC has shown dose-limiting nephrotoxicity due to radiopeptide retention in the proximal tubules. Pharmacological pr...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-016-0240-5

    authors: Chan HS,Konijnenberg MW,Daniels T,Nysus M,Makvandi M,de Blois E,Breeman WA,Atcher RW,de Jong M,Norenberg JP

    更新日期:2016-12-01 00:00:00

  • Voxel-based statistical analysis and quantification of amyloid PET in the Japanese Alzheimer's disease neuroimaging initiative (J-ADNI) multi-center study.

    abstract:BACKGROUND:Amyloid PET plays a vital role in detecting the accumulation of in vivo amyloid-β (Aβ). The quantification of Aβ accumulation has been widely performed using the region of interest (ROI)-based mean cortical standardized uptake value ratio (mcSUVR). However, voxel-based statistical analysis has not been well ...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-019-0561-2

    authors: Akamatsu G,Ikari Y,Ohnishi A,Matsumoto K,Nishida H,Yamamoto Y,Senda M,Japanese Alzheimer’s Disease Neuroimaging Initiative.

    更新日期:2019-09-18 00:00:00

  • First in-human radiation dosimetry of the gastrin-releasing peptide (GRP) receptor antagonist 68Ga-NODAGA-MJ9.

    abstract:BACKGROUND:Gastrin-releasing peptide receptor antagonists have promise in theranostics of several highly incident tumours, including prostate and breast. This study presents the first human dosimetry of 68Ga-NODAGA-MJ9 in the first five consecutive patients with recurrent prostate cancer included in a dual-tracer posit...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-018-0462-9

    authors: Gnesin S,Cicone F,Mitsakis P,Van der Gucht A,Baechler S,Miralbell R,Garibotto V,Zilli T,Prior JO

    更新日期:2018-12-12 00:00:00

  • Peptide receptor radionuclide therapy (PRRT) with [(177)Lu-DOTA(0),Tyr(3)]octreotate in combination with RAD001 treatment: further investigations on tumor metastasis and response in the rat pancreatic CA20948 tumor model.

    abstract:BACKGROUND:Previously, we reported on the unexpected development of distant metastases in the subcutaneous rat pancreas CA20948 tumor model after 4.5 weeks of treatment with RAD001-only or in combination with [(177)Lu-DOTA(0),Tyr(3)]octreotate ((177)Lu-DOTATATE) (Cancer Res. 73:12-8, 2013). Moreover, the combination th...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-014-0021-y

    authors: Bison SM,Pool SE,Koelewijn SJ,van der Graaf LM,Groen HC,Melis M,de Jong M

    更新日期:2014-05-30 00:00:00